• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Thyroid controversy--stimulating antibodies.

作者信息

Davies T F, Roti E, Braverman L E, DeGroot L J

机构信息

Mount Sinai School of Medicine, New York, New York, USA.

出版信息

J Clin Endocrinol Metab. 1998 Nov;83(11):3777-85. doi: 10.1210/jcem.83.11.5056-1.

DOI:10.1210/jcem.83.11.5056-1
PMID:9814446
Abstract
摘要

相似文献

1
Thyroid controversy--stimulating antibodies.
J Clin Endocrinol Metab. 1998 Nov;83(11):3777-85. doi: 10.1210/jcem.83.11.5056-1.
2
A TSHR-LH/CGR chimera that measures functional thyroid-stimulating autoantibodies (TSAb) can predict remission or recurrence in Graves' patients undergoing antithyroid drug (ATD) treatment.一种 TSHR-LH/CGR 嵌合体，可测量功能型甲状腺刺激自身抗体（TSAb），可预测 Graves 病患者接受抗甲状腺药物（ATD）治疗后的缓解或复发。
J Clin Endocrinol Metab. 2012 Jul;97(7):E1080-7. doi: 10.1210/jc.2011-2897. Epub 2012 Apr 6.
3
[Current topics on immunological laboratory tests-thyroid diseases].
Rinsho Byori. 2004 Sep;52(9):751-8.
4
Application of a bioassay with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSH-receptor.应用CHO细胞生物测定法常规检测促甲状腺激素受体刺激和阻断自身抗体。
Horm Metab Res. 1998 Mar;30(3):162-8. doi: 10.1055/s-2007-978858.
5
Comparison of new different assay systems for thyrotropin receptor antibodies with reference to thyroid-stimulating antibodies and thyroid stimulation-blocking antibodies in Graves' disease.在格雷夫斯病中，参照甲状腺刺激抗体和甲状腺刺激阻断抗体，对促甲状腺素受体抗体新的不同检测系统进行比较。
Int J Clin Pharmacol Res. 2004;24(4):111-6.
6
Binding, stimulating and blocking TSH receptor antibodies to the thyrotropin receptor as predictors of relapse of Graves' disease after withdrawal of antithyroid treatment.与促甲状腺素受体结合、刺激及阻断的促甲状腺素受体抗体作为抗甲状腺治疗停药后Graves病复发的预测指标
Horm Metab Res. 2005 Dec;37(12):745-50. doi: 10.1055/s-2005-921102.
7
Sensitivity of assays for TSH-receptor antibodies.促甲状腺激素受体抗体检测方法的敏感性。
J Endocrinol Invest. 2016 Oct;39(10):1195-6. doi: 10.1007/s40618-016-0520-y. Epub 2016 Aug 16.
8
[Anti-TSH receptor antibody (TBII, TSAb)].[抗促甲状腺激素受体抗体（TBII，TSAb）]
Nihon Rinsho. 2005 Aug;63 Suppl 8:277-9.
9
[Antibodies against TSH receptors (TRAb) as indicators in prognosing the effectiveness of Tiamazol therapy for Grave's Disease].[抗促甲状腺素受体抗体（TRAb）作为预测甲巯咪唑治疗格雷夫斯病疗效的指标]
Wiad Lek. 2003;56(7-8):303-7.
10
[The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].[血清甲状腺自身抗体、碘摄入量与Graves病的发生发展及预后的关系]
Zhonghua Nei Ke Za Zhi. 2006 Feb;45(2):95-9.

引用本文的文献

1
Long-Term Antithyroid Drug Therapy in Smoldering or Fluctuating-Type Graves' Hyperthyroidism with Potassium Iodide.碘化钾用于隐匿型或波动型格雷夫斯甲亢的长期抗甲状腺药物治疗
Endocrinol Metab (Seoul). 2024 Dec;39(6):827-838. doi: 10.3803/EnM.2024.2079. Epub 2024 Oct 16.
2
Evaluation of analytic and clinical performance of two immunoassays for detecting thyroid-stimulating receptor antibody in the diagnosis of Graves' disease.评价两种免疫分析法在 Graves 病诊断中检测甲状腺刺激受体抗体的分析和临床性能。
J Clin Lab Anal. 2021 Dec;35(12):e23950. doi: 10.1002/jcla.23950. Epub 2021 Nov 9.
3
The Clinical Value and Variation of Antithyroid Antibodies during Pregnancy.
妊娠期甲状腺自身抗体的临床价值及变化。
Dis Markers. 2020 Oct 21;2020:8871951. doi: 10.1155/2020/8871951. eCollection 2020.
4
Clinical diagnosis of Graves' or non-Graves' hyperthyroidism compared to TSH receptor antibody test.与促甲状腺激素受体抗体检测相比，格雷夫斯病或非格雷夫斯病甲亢的临床诊断
Endocr Connect. 2018 Apr;7(4):504-510. doi: 10.1530/EC-18-0082. Epub 2018 Mar 12.
5
Pediatric Graves' disease: management in the post-propylthiouracil Era.儿童格雷夫斯病：丙硫氧嘧啶时代后的管理
Int J Pediatr Endocrinol. 2014;2014(1):10. doi: 10.1186/1687-9856-2014-10. Epub 2014 Jun 16.
6
Thyroid peroxidase autoantibodies are associated with a lesser likelihood of late reversion to hyperthyroidism after successful non-ablative treatment of Graves' disease in Croatian patients.在克罗地亚患者中，甲状腺过氧化物酶自身抗体与格雷夫斯病成功非消融治疗后晚期甲亢复发可能性较低相关。
J Endocrinol Invest. 2014 Jan;37(1):71-7. doi: 10.1007/s40618-013-0026-9. Epub 2014 Jan 8.
7
Clinical review: Clinical utility of TSH receptor antibodies.临床综述：促甲状腺激素受体抗体的临床应用价值。
J Clin Endocrinol Metab. 2013 Jun;98(6):2247-55. doi: 10.1210/jc.2012-4309. Epub 2013 Mar 28.
8
Is the measurement of inferior thyroid artery blood flow velocity by color-flow Doppler ultrasonography useful for differential diagnosis between gestational transient thyrotoxicosis and Graves' disease? A prospective study.彩色多谱勒超声检测甲状腺下动脉血流速度在鉴别妊娠一过性甲状腺毒症与 Graves 病中的作用：一项前瞻性研究。
Clinics (Sao Paulo). 2012;67(2):125-9. doi: 10.6061/clinics/2012(02)06.
9
Graves disease in childhood: a review of the options for diagnosis and treatment.儿童格雷夫斯病：诊断与治疗选择综述
Paediatr Drugs. 2003;5(2):95-102. doi: 10.2165/00128072-200305020-00003.
10
Thyrotoxicosis due to metastatic papillary thyroid cancer in a patient with Graves' disease.格雷夫斯病患者发生转移性甲状腺乳头状癌所致甲状腺毒症。
J Endocrinol Invest. 2002 Jul-Aug;25(7):639-42. doi: 10.1007/BF03345090.